GO:0033038 bitter taste receptor activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0033038 bitter taste receptor activity is a molecular function defined as combining with soluble bitter compounds to initiate a change in cell activity, responsible for the sense of bitter taste.
• The primary receptors are the TAS2R family of G protein-coupled receptors, which detect thousands of structurally diverse bitter agonists.
• TAS2R14 is a key human bitter taste receptor and has been proposed as a drug target, with activation by cholesterol and intracellular tastants.
• Bitter taste receptors are expressed beyond the tongue, including in skeletal muscle, kidney, and metabolic tissues, where they regulate glucose and lipid metabolism.
• TAS2R46 in human skeletal muscle is functional and may influence muscle physiology.
• Sodium chloride modulates human bitter taste receptor responses, indicating that ionic environment affects receptor activity.
Description
Bitter taste receptor activity (GO:0033038) is a molecular function that enables cells to detect soluble bitter compounds and trigger downstream signaling. This activity is mediated primarily by the TAS2R family of G protein-coupled receptors (GPCRs), which are expressed in taste receptor cells of the tongue and in various extraoral tissues. The ability to sense bitterness is crucial for avoiding potentially toxic substances, but emerging evidence shows that these receptors also play roles in diverse physiological processes, including metabolism and immune responses. Researchers study bitter taste receptor activity to understand taste perception, develop bitter-masking strategies, and explore new therapeutic targets for metabolic and inflammatory diseases. The recent discovery that TAS2R14 can be activated by cholesterol and intracellular tastants highlights the complexity of ligand recognition and signaling. This article provides a comprehensive overview of the mechanism, key genes, and research methods for studying GO:0033038, based on authoritative QuickGO data and verified PubMed literature.
bitter taste receptor activity At A Glance
| GO ID | GO:0033038 |
|---|---|
| GO term | bitter taste receptor activity |
| Ontology | molecular_function |
| Synonym | none |
| Definition | Combining with soluble bitter compounds to initiate a change in cell activity. These receptors are responsible for the sense of bitter taste. |
| Major function | Detection of bitter compounds and initiation of intracellular signaling |
| Representative genes | TAS2R family (e.g., TAS2R14, TAS2R46, TAS2R4, TAS2R2) |
| Cellular location | Plasma membrane of taste receptor cells and extraoral tissues |
| Signaling pathway | G protein-coupled receptor signaling, often via gustducin |
What Is GO:0033038?
According to the Gene Ontology, GO:0033038 bitter taste receptor activity is defined as combining with soluble bitter compounds to initiate a change in cell activity, with these receptors being responsible for the sense of bitter taste. In other words, it is the molecular function of a receptor protein that binds bitter molecules and transmits a signal into the cell, ultimately leading to a cellular response. This activity is distinct from other taste modalities such as sweet or umami, and it is typically associated with the TAS2R gene family.
Why Is bitter taste receptor activity Important in Cell Biology?
Bitter taste receptor activity is important because it mediates the detection of potentially toxic compounds in food, influencing dietary choices and safety. Beyond taste, these receptors are expressed in many extraoral tissues where they regulate processes such as glucose homeostasis, lipid metabolism, and immune responses. Dysregulation of bitter taste receptors has been linked to metabolic disorders, and TAS2R14 is considered a promising drug target for conditions like asthma and cancer. Understanding the molecular mechanisms of bitter taste receptor activity can lead to new strategies for treating metabolic diseases and for modulating taste perception in food science.
• Mediates the sense of bitter taste, helping organisms avoid toxic substances.
• TAS2R14 is a potential drug target for asthma and other diseases.
• Bitter taste receptors in skeletal muscle may influence muscle physiology and energy metabolism.
• Activation of TAS2R4 alleviates diabetic nephropathy in mice, suggesting therapeutic potential.
• Bitter taste receptors regulate glycolipid metabolism, linking taste to metabolic health.
• Sodium chloride modulates bitter taste receptor responses, affecting food taste.
• Chemoinformatics approaches help identify bitter agonists in food.
• TAS2R2 is the 26th human bitter taste receptor, expanding the repertoire.
• Bitter taste receptors are expressed in extraoral tissues, indicating broader roles.
• Understanding bitter taste receptor activity aids in designing bitter-masking compounds.
What Happens During bitter taste receptor activity?
Ligand binding and receptor activation
In simple terms: A bitter molecule binds to the receptor on the cell surface, like a key fitting into a lock.
Bitter taste receptor activity begins when a soluble bitter compound binds to the extracellular domain of a TAS2R receptor. This binding induces a conformational change in the receptor, enabling it to activate intracellular heterotrimeric G proteins, typically gustducin. Recent studies show that TAS2R14 can also be activated by cholesterol and intracellular tastants, revealing diverse activation mechanisms. The binding specificity varies among the ~25 human TAS2Rs, allowing detection of thousands of bitter substances.
G protein activation and second messenger signaling
In simple terms: The activated receptor turns on a G protein, which then triggers a cascade of signals inside the cell.
Upon activation, the TAS2R receptor acts as a guanine nucleotide exchange factor for the G protein alpha subunit (e.g., gustducin). This leads to the dissociation of G alpha from G beta-gamma subunits. The released G beta-gamma can activate phospholipase C beta 2 (PLCβ2), producing inositol trisphosphate (IP3) and diacylglycerol (DAG). IP3 triggers calcium release from intracellular stores, while DAG activates protein kinase C. This signaling cascade ultimately leads to depolarization and neurotransmitter release in taste cells.
Calcium influx and cellular response
In simple terms: Calcium levels rise inside the cell, causing it to send a signal to the brain.
The increase in intracellular calcium activates the transient receptor potential cation channel subfamily M member 5 (TRPM5), leading to sodium influx and membrane depolarization. This depolarization opens voltage-gated calcium channels, causing further calcium entry and release of ATP as a neurotransmitter. The signal is then transmitted to afferent nerve fibers, ultimately perceived as bitter taste. In extraoral tissues, similar signaling can regulate cell proliferation, migration, and secretion.
Receptor desensitization and regulation
In simple terms: After signaling, the receptor is turned off to prevent overstimulation.
Following activation, bitter taste receptors undergo desensitization via phosphorylation by G protein-coupled receptor kinases (GRKs) and subsequent binding of arrestins. This process uncouples the receptor from G proteins and promotes internalization. Regulatory mechanisms ensure that the cell can respond to repeated stimuli without excessive signaling. The activity of TAS2Rs can also be modulated by ions such as sodium chloride, which affects receptor responses.
Key Genes Involved in GO:0033038 bitter taste receptor activity
The following genes encode the primary receptors and signaling components involved in bitter taste receptor activity.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TAS2R14 | Bitter taste receptor activated by diverse compounds, including cholesterol and intracellular tastants | Drug target for asthma and cancer; structural studies |
| TAS2R46 | Bitter taste receptor expressed in skeletal muscle | Role in muscle physiology and energy metabolism |
| TAS2R4 | Bitter taste receptor; activation alleviates diabetic nephropathy in mice | Therapeutic target for kidney disease |
| TAS2R2 | The 26th human bitter taste receptor | Expands the repertoire of bitter detection |
| TAS2R1 | Bitter taste receptor for various agonists | Model for ligand specificity |
| TAS2R10 | Bitter taste receptor | Food science and bitter masking |
| TAS2R16 | Bitter taste receptor for salicin | Evolutionary and functional studies |
| TAS2R38 | Bitter taste receptor for PROP/PTC | Genetic variation and taste perception |
| TAS2R39 | Bitter taste receptor | Agonist profiling |
| TAS2R43 | Bitter taste receptor | Ligand discovery |
| TAS2R44 | Bitter taste receptor | Receptor deorphanization |
| TAS2R47 | Bitter taste receptor | Food bitter compounds |
| GNAT3 | Gustducin alpha subunit, mediates bitter taste signaling | Key signaling component |
| PLCβ2 | Phospholipase C beta 2, produces IP3 and DAG | Second messenger generation |
| TRPM5 | Calcium-activated cation channel, depolarizes taste cells | Signal transduction |
| GNB3 | G protein beta 3 subunit, forms heterotrimer with gustducin | Signaling modulation |
| GNG13 | G protein gamma 13 subunit, part of gustducin heterotrimer | Signaling modulation |
How Is bitter taste receptor activity Regulated?
Bitter taste receptor activity is regulated at multiple levels. Receptor desensitization occurs via phosphorylation by GRKs and arrestin binding, which uncouples the receptor from G proteins. The ionic environment, such as the presence of sodium chloride, can modulate receptor responses. Additionally, the expression of TAS2Rs can be regulated transcriptionally, and their activity may be influenced by interactions with other proteins. In extraoral tissues, bitter taste receptors are regulated by metabolic and inflammatory signals, contributing to their diverse physiological roles.
bitter taste receptor activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TAS2R4 | Diabetic nephropathy | Knockout mouse, overexpression in kidney cells |
| TAS2R14 | Asthma, cancer | Knockout and knock-in cell lines, xenograft models |
| TAS2R46 | Muscle metabolism | Skeletal muscle-specific knockout mice |
| TAS2R38 | Taste perception and dietary behavior | Human genetic association studies, knock-in mice |
| TAS2R2 | Bitter taste detection | Heterologous expression systems |
Bitter taste receptors in metabolic diseases
Bitter taste receptors are expressed in metabolic tissues such as skeletal muscle, adipose tissue, and the gastrointestinal tract, where they regulate glycolipid metabolism. Activation of TAS2R4 alleviates diabetic nephropathy in mice, suggesting that targeting bitter taste receptors could be a therapeutic strategy for diabetes-related complications. TAS2R46 in human skeletal muscle may influence muscle energy homeostasis. These findings link bitter taste receptor activity to obesity, diabetes, and metabolic syndrome.
Bitter taste receptors in kidney disease
TAS2R4 activation has been shown to alleviate diabetic nephropathy in mice, reducing renal injury and fibrosis. This indicates that bitter taste receptors may play a protective role in kidney disease and could be targeted for therapy. The mechanisms likely involve anti-inflammatory and anti-fibrotic effects, though further research is needed.
Bitter taste receptors as drug targets in cancer and asthma
TAS2R14 is considered a drug target for asthma and cancer. In asthma, bitter taste receptor agonists induce bronchodilation, while in cancer, they may inhibit proliferation or induce apoptosis. The discovery that TAS2R14 can be activated by cholesterol and intracellular tastants opens new avenues for drug development. However, the precise roles in disease require further investigation.
From bitter taste receptor activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does TAS2R14 mediate cholesterol sensing? | Point mutation of cholesterol-binding residues in TAS2R14, knock-in mice |
| What is the role of TAS2R4 in diabetic nephropathy? | TAS2R4 knockout and overexpression mouse models |
| How does TAS2R46 affect muscle physiology? | Skeletal muscle-specific TAS2R46 knockout mice |
| Which ligands activate TAS2R2? | Heterologous expression of TAS2R2 in HEK293 cells, calcium imaging |
| Does sodium chloride modulate bitter taste? | Point mutations in TAS2R ligand-binding pocket, functional assays |
| Can bitter taste receptors regulate glycolipid metabolism? | TAS2R knockout mice fed high-fat diet, metabolic profiling |
How to Study the bitter taste receptor activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Calcium imaging | Intracellular calcium changes upon receptor activation | High-throughput screening of bitter agonists |
| Chemoinformatics | Chemical features of bitter compounds | Predicting new agonists |
| Knockout mouse models | Physiological effects of receptor loss | Studying disease roles |
| Site-directed mutagenesis | Function of specific receptor residues | Mapping ligand-binding sites |
| Heterologous expression | Receptor activity in non-native cells | Deorphanization of TAS2Rs |
| Electrophysiology | Ion channel activity and membrane potential | Taste cell signaling |
| RNA-seq | Gene expression profiles | Identifying TAS2R expression in tissues |
| Proteomics | Protein interactions and modifications | Receptor signaling complexes |
Calcium imaging and functional assays
Calcium imaging is widely used to measure bitter taste receptor activation. Cells expressing TAS2Rs are loaded with calcium-sensitive dyes, and agonist-induced calcium influx is monitored. This method allows high-throughput screening of bitter compounds and assessment of receptor activity. It can also be used to study modulation by ions such as sodium chloride.
Ligand binding and chemoinformatics
Chemoinformatics approaches predict bitter taste receptor agonists by analyzing chemical features of known bitter compounds. These methods help identify new ligands and understand structure-activity relationships. Experimental validation often involves heterologous expression of receptors and functional assays.
Genetic and transgenic models
Knockout and transgenic mouse models are essential to study the physiological roles of bitter taste receptors. For example, TAS2R4 knockout mice have been used to demonstrate its role in diabetic nephropathy. Tissue-specific knockouts, such as skeletal muscle-specific TAS2R46, allow investigation of extraoral functions.
Structural biology and mutagenesis
Structural studies of TAS2R14 have revealed binding sites for cholesterol and intracellular tastants. Site-directed mutagenesis combined with functional assays helps identify key residues involved in ligand binding and receptor activation. These approaches provide mechanistic insights into bitter taste receptor activity.
How CRISPR Can Be Used to Study GO:0033038 bitter taste receptor activity
Knockout
CRISPR knockout of TAS2R genes in cell lines or animal models can abolish bitter taste receptor activity, allowing researchers to study loss-of-function phenotypes. For example, knocking out TAS2R4 in mice has been used to demonstrate its protective role in diabetic nephropathy. Knockout of TAS2R46 in skeletal muscle cells can reveal its role in energy metabolism.
Point Mutation
CRISPR point mutation can introduce specific amino acid changes in TAS2R receptors to study ligand binding and signaling. For instance, mutating cholesterol-binding residues in TAS2R14 can test their role in receptor activation. Point mutations in TAS2R38 are known to affect bitter taste perception.
Knock-in
CRISPR knock-in can insert reporter tags or human TAS2R genes into model organisms. Tagged knock-in of TAS2R14 allows visualization of receptor localization and trafficking. Knock-in of human TAS2R genes into mice can humanize taste perception for studying human-specific ligands.
Overexpression
CRISPR overexpression (e.g., via CRISPRa) can increase TAS2R expression to study gain-of-function effects. Overexpressing TAS2R4 in kidney cells can enhance its protective effects in diabetic nephropathy models. Overexpression of TAS2R14 in cancer cell lines can help evaluate its potential as a drug target.
How EDITGENE Supports bitter taste receptor activity Research
Researchers studying bitter taste receptor activity-related genes often need to determine whether a candidate gene is causally involved in taste perception, metabolic regulation, or disease. EDITGENE provides comprehensive CRISPR-based services to accelerate this research, from gene knockout to precise point mutations and knock-in models.
Contact EDITGENE today to design your custom CRISPR model for bitter taste receptor activity research.
Frequently Asked Questions About bitter taste receptor activity
What is bitter taste receptor activity?
Bitter taste receptor activity (GO:0033038) is the molecular function of binding soluble bitter compounds and initiating a cellular response, primarily mediated by TAS2R receptors.
What genes are involved in bitter taste receptor activity?
The main genes are the TAS2R family, including TAS2R14, TAS2R46, TAS2R4, and TAS2R2, as well as signaling components like GNAT3, PLCβ2, and TRPM5.
How do bitter taste receptors work?
They are G protein-coupled receptors that, upon binding bitter compounds, activate gustducin and downstream signaling, leading to calcium release and cell depolarization.
What diseases are linked to bitter taste receptors?
They have been linked to metabolic disorders, diabetic nephropathy, asthma, and cancer.
Can bitter taste receptors be drug targets?
Yes, TAS2R14 is considered a drug target for asthma and cancer, and TAS2R4 activation alleviates diabetic nephropathy in mice.
How can I study bitter taste receptor activity in the lab?
Common methods include calcium imaging, chemoinformatics, knockout mouse models, and site-directed mutagenesis.
What is the role of TAS2R14?
TAS2R14 is a bitter taste receptor activated by diverse compounds, including cholesterol and intracellular tastants, and is a potential drug target.
Are bitter taste receptors only in the tongue?
No, they are also expressed in extraoral tissues such as skeletal muscle, kidney, and metabolic tissues.
How does sodium chloride affect bitter taste?
Sodium chloride can modulate human bitter taste receptor responses, altering the perception of bitterness.
What CRISPR models are available for bitter taste receptor research?
EDITGENE provides knockout, point mutation, knock-in, and overexpression models, as well as CRISPR library screening and bioinformatics services.
Conclusion
Bitter taste receptor activity (GO:0033038) is a fundamental molecular function mediated by the TAS2R family of GPCRs, with roles beyond taste in metabolism and disease. Understanding its mechanisms and regulation offers opportunities for therapeutic development and food science. EDITGENE's CRISPR services provide powerful tools to dissect the functions of TAS2Rs and their signaling pathways.
References
- 1. Kim Y et al.. 2024. Bitter taste receptor activation by cholesterol and an intracellular tastant.. Nature 628(8008):664-671 PMID: 38600377
- 2. Talmon M et al.. 2023. Bitter taste receptor (TAS2R) 46 in human skeletal muscle: expression and activity.. Front Pharmacol 14:1205651 PMID: 37771728
- 3. Gu PP et al.. 2025. Activation of bitter taste receptor TAS2R4 alleviates diabetic nephropathy in mice.. Biochem Pharmacol 237:116941 PMID: 40228633
- 4. Lang T et al.. 2023. Activation Profile of TAS2R2, the 26th Human Bitter Taste Receptor.. Mol Nutr Food Res 67(11):e2200775 PMID: 36929150
- 5. Waterloo LAW et al.. 2022. The Bitter Taste Receptor TAS2R14 as a Drug Target.. Chimia (Aarau) 76(5):418-424 PMID: 38069713
- 6. Bayer S et al.. 2021. Chemoinformatics View on Bitter Taste Receptor Agonists in Food.. J Agric Food Chem 69(46):13916-13924 PMID: 34762411
- 7. Kumar P et al.. 2024. Influence of Sodium Chloride on Human Bitter Taste Receptor Responses.. J Agric Food Chem 72(18):10531-10536 PMID: 38663860
- 8. Bao T et al.. 2025. Bitter taste receptor-mediated regulation of glycolipid metabolism and natural product-based targeted therapies: A review.. Int J Biol Macromol 320(Pt 2):145759 PMID: 40639528
